167 related articles for article (PubMed ID: 25027693)
1. Important role of SUMOylation of Spliceosome factors in prostate cancer cells.
Wen D; Xu Z; Xia L; Liu X; Tu Y; Lei H; Wang W; Wang T; Song L; Ma C; Xu H; Zhu W; Chen G; Wu Y
J Proteome Res; 2014 Aug; 13(8):3571-82. PubMed ID: 25027693
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the activity and substrate specificity of the human SENP family of SUMO proteases.
Mendes AV; Grou CP; Azevedo JE; Pinto MP
Biochim Biophys Acta; 2016 Jan; 1863(1):139-47. PubMed ID: 26522917
[TBL] [Abstract][Full Text] [Related]
3. Computational Investigation of SENP:SUMO Protein-Protein Interaction for Structure Based Drug Design.
Kumar A; Zhang KY
Mol Inform; 2013 Mar; 32(3):267-80. PubMed ID: 27481522
[TBL] [Abstract][Full Text] [Related]
4. Advances in the development of SUMO specific protease (SENP) inhibitors.
Kumar A; Zhang KY
Comput Struct Biotechnol J; 2015; 13():204-11. PubMed ID: 25893082
[TBL] [Abstract][Full Text] [Related]
5. Chemical Tools and Biochemical Assays for SUMO Specific Proteases (SENPs).
Jia Y; Claessens LA; Vertegaal ACO; Ovaa H
ACS Chem Biol; 2019 Nov; 14(11):2389-2395. PubMed ID: 31361113
[TBL] [Abstract][Full Text] [Related]
6. Role of desumoylation in the development of prostate cancer.
Cheng J; Bawa T; Lee P; Gong L; Yeh ET
Neoplasia; 2006 Aug; 8(8):667-76. PubMed ID: 16925949
[TBL] [Abstract][Full Text] [Related]
7. The function of SUMOylation and its crucial roles in the development of neurological diseases.
Chen X; Zhang Y; Wang Q; Qin Y; Yang X; Xing Z; Shen Y; Wu H; Qi Y
FASEB J; 2021 Apr; 35(4):e21510. PubMed ID: 33710677
[TBL] [Abstract][Full Text] [Related]
8. SUMO proteases: redox regulation and biological consequences.
Xu Z; Chan HY; Lam WL; Lam KH; Lam LS; Ng TB; Au SW
Antioxid Redox Signal; 2009 Jun; 11(6):1453-84. PubMed ID: 19186998
[TBL] [Abstract][Full Text] [Related]
9. Sumoylation Negatively Regulates CSR1-Dependent Prostate Cancer Cell Death.
Luo HR; Liu Y; Wan XD; Li JL; Wu M; Zhang QM; Wu DL; Zhao X; Wang TR
Cell Physiol Biochem; 2018; 46(5):1861-1867. PubMed ID: 29705808
[TBL] [Abstract][Full Text] [Related]
10. SENP Proteases as Potential Targets for Cancer Therapy.
Tokarz P; Woźniak K
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33923236
[TBL] [Abstract][Full Text] [Related]
11. Identification of SENP1 inhibitors through in silico screening and rational drug design.
Zhao Y; Wang Z; Zhang J; Zhou H
Eur J Med Chem; 2016 Oct; 122():178-184. PubMed ID: 27344494
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a Dual SENP1 and SENP2 Inhibitor.
Brand M; Bommeli EB; Rütimann M; Lindenmann U; Riedl R
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292935
[TBL] [Abstract][Full Text] [Related]
13. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
[TBL] [Abstract][Full Text] [Related]
14. The SUMO-specific protease family regulates cancer cell radiosensitivity.
Hu C; Jiang X
Biomed Pharmacother; 2019 Jan; 109():66-70. PubMed ID: 30396093
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of benzodiazepine-based SUMO-specific protease 1 inhibitors.
Qiao Z; Wang W; Wang L; Wen D; Zhao Y; Wang Q; Meng Q; Chen G; Wu Y; Zhou H
Bioorg Med Chem Lett; 2011 Nov; 21(21):6389-92. PubMed ID: 21930380
[TBL] [Abstract][Full Text] [Related]
16. Development of small molecule inhibitors and probes of human SUMO deconjugating proteases.
Albrow VE; Ponder EL; Fasci D; Békés M; Deu E; Salvesen GS; Bogyo M
Chem Biol; 2011 Jun; 18(6):722-32. PubMed ID: 21700208
[TBL] [Abstract][Full Text] [Related]
17. SUMO1/sentrin/SMT3 specific peptidase 2 modulates target molecules and its corresponding functions.
Liu SL; Gao FH
Biochimie; 2018 Sep; 152():6-13. PubMed ID: 29908207
[TBL] [Abstract][Full Text] [Related]
18. Development and evaluation of a highly reliable assay for SUMO-specific protease inhibitors.
Xie W; Wang Z; Zhang J; Wang L; Zhao Y; Zhou H
Bioorg Med Chem Lett; 2016 May; 26(9):2124-8. PubMed ID: 27032332
[TBL] [Abstract][Full Text] [Related]
19. Pc2-mediated SUMOylation of WWOX is essential for its suppression of DU145 prostate tumorigenesis.
Choi HJ; Park JH; Park JH; Lee KB; Oh SM
FEBS Lett; 2015 Dec; 589(24 Pt B):3977-88. PubMed ID: 26592150
[TBL] [Abstract][Full Text] [Related]
20. DeSUMOylation: An Important Therapeutic Target and Protein Regulatory Event.
Huang CJ; Wu D; Khan FA; Huo LJ
DNA Cell Biol; 2015 Nov; 34(11):652-60. PubMed ID: 26309017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
